Article Per Year (5 Year)
p-Index From 2019 - 2024
1.642
P-Index
This Author published in this journals
All Journal Jurnal Anestesiologi Indonesia Nusantara Medical Science Journal Journal of Anesthesiology and Clinical Research Majalah Anestesia & Critical Care (MACC)
Andi Muhammad Takdir Musba
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Materials Science & Nanotechnology Medicine & Pharmacology Neuroscience Public Health

Published : 9 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Journal of Anesthesiology and Clinical Research

 1 
Pharmacological Therapy in Sub-Acute Postherpetic Neuralgia Patients: A Case Report Alamsyah Irwan; Andi Muhammad Takdir Musba
Journal of Anesthesiology and Clinical Research Vol. 3 No. 2 (2022): Journal of Anesthesiology and Clinical Research
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/jacr.v3i2.248

Abstract

Introduction: Herpes zoster is caused by the reactivation of the varicella-zoster virus. Post-herpetic neuralgia (PHN) is pain due to a zoster that persists 1 month after vesicle development. Usually, the prognosis is good, but some patients continue to suffer from long-term pain. The goal of PHN therapy is to reduce pain and improve quality of life. Antiepileptic drugs and tricyclic antidepressants are the first choices. Case presentation: A 32-year-old man presented with complaints of left-sided headache radiating like electricity to the left eyelid for ± 6 weeks, sudden spikes of nails, numbness/cramping sensation, and pain when touched (allodynia), and hypoesthesia. His previous medical history was herpes zoster, and he received acyclovir and symptomatic therapy such as paracetamol, mefenamic acid, dexamethasone, and cetirizine. The patient presented with a 6-7/10 visual analog scale (VAS) and was diagnosed with subacute post-herpetic neuralgia. The patient received Lyrica (Pregabalin) 50 mg 2 times a day 1 tablet, amitriptyline 10 mg once a day 1 tablet, Ultracet (Tramadol 37.5 mg + paracetamol 375 mg) 3 times a day 1 tablet. After the 14th day, the patient's VAS was reduced to 2/10, but side effects occurred in the form of dry lips and frequent sleepiness, and continued treatment with only Amitriptyline 10 mg/day. Conclusion: Rapid therapy for PHN provides prevention of refractory pain, making it difficult to provide adequate therapy. Giving first-line therapy in subacute PHN using amitriptyline, pregabalin, and tramadol agents have a very good effect in overcoming pain in subacute PHN, but it is necessary to monitor the side effects that occur due to potentiation of these three drugs.
Co-Authors Alamsyah A.A Husain Alamsyah Ambo Ala Husain Alamsyah Irwan Alamsyah Irwan Albert Winata Andi Adil Andi Salahuddin Andi Taufik Amiruddin Ari Santri Palinrungi Fadli Rachman Fauzan Bachtiar Amin Haizah Nurdin Hisbullah Muh Ramli Ahmad Ratnawati Ratnawati R Syafri Arif Syafri Kamsul Arif Syamsul Salam Taufik Anshori Tekad Ariffianto